- Continue Shopping
- Your Cart is Empty
Hexoskin in Basel for the Digital Biomarkers in Clinical Trials & Clinical Trial Innovation Summits June 23-24
Hexoskin is proud to sponsor this week the 9th Digital Biomarkers in Clinical Trials Summit and the 6th Clinical Trial Innovation Summit, hosted in partnership with Roche in Basel, Switzerland.
View full article →Hexoskin in San Diego for BIO 2026
Hexoskin will be in San Diego this June 22-24 for the BIO 2026 International Convention, the world's largest and most comprehensive event for the global biotechnology and life sciences industry. Hosted by the Biotechnology Innovation Organization, the gathering brings together over 20,000 leaders from startups, Pharma companies, academia, and government agencies
View full article →Hexoskin @ HLTH 2025
Hexoskin will be presenting its latest products and clinical advancements at HLTH USA 2025 next week in Las Vegas.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.
We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
HITLAB September 2024 Symposium on September 26
Hexoskin's CEO Pierre-Alexandre Fournier will be speaking at the HITLAB Digital Health Symposium on Digital Health this September 26th. The event will be streamed online and is free to attend.
Along with speakers from Genentech, Pfizer, Merck, Samsung, and many other innovative companies in health technologies and life sciences, Fournier will discuss the current state of digital biomarkers, wearables, and articificial intelligence in medicine.
For more than 20 years, HITLAB (Healthcare Innovation & Technology Lab) has been at the forefront of digital health research. The Columbia University-based organization partners with innovative healthcare technologies and life sciences companies to improve global health delivery and healthcare worldwide. HITLAB uses rigorous research and evidence-based methods to identify the best digital health solutions for their partners.
HITLAB Virtual Session: the Impact of Wearable Technology on Digital Diagnostics
Today we attended the 6th session of HITLAB's BT1 Virtual Knowledge Convene to discuss "The Impact of Wearable Technology on Digital Diagnostics". This was an opportunity to talk and discuss about the past, present, and future of medical wearables with Columbia University's HITLAB international community.
A few of the topics we covered:
• How wearables are revolutionizing healthcare data collection
• The potential of wearables for early disease detection and remote patient monitoring
• The future of personalized medicine powered by wearable tech.
Mayo Clinic Seminar on Wearables and Digital Biomarkers in Neuroscience
Our CEO Pierre-Alexandre Fournier was invited by Mayo Clinic to give a seminar on medical wearables and digital biomarkers this week. Thanks again to Dr Jonathon J. Parker, MD PhD, Teryn Johnson, Ph.D., and Bobby Mohan from the Neurosurgery department for organizing the event!
We had the chance to share details about many Hexoskin projects , including our collaboration with Centre de recherche du CHUM (CRCHUM) on epilepsy research, and R&D on respiratory and rare diseases.
We also discussed the importance of running the right trials to validate the digital biomarkers that make medical wearables valuable in different care settings, e.g. before, during, and after hospitalizations. Convincing data from these trials are essential to get through regulatory, reimbursement, and adoption challenges.
Hexoskin @ HITLAB New York City Health Innovation Week
This week Hexoskin was participating in HITLAB's New York City Health Innovation Week in Manhattan. The event was attended by dozens of startups and large life science companies such as Merck, Novo Nordisk, and Sanofi.
To learn more about Hexoskin's involvement in pharma trials and clinical research, please write us at: contact@hexoskin.com
Hexoskin at the American Telemedicine Association Nexus 2024 Conference in Phoenix
The American Telemedicine Association has invited Hexoskin's CEO Pierre-Alexandre Fournier to present at the ATA Nexus 2024 conference this May 5th in Phoenix, Arizona.
Mr. Fournier will talk about today’s use cases for medical wearables in telemedicine, with examples from over 10 years of experience in working with patients and professionals, answering clinical questions using data from wearables and mobile devices.
The Hexoskin OneView platform is used by health professionals involved in deploying health programs and decentralized trials at scale with wearables and patient reported outcomes.
This code gives you a $350 discount on the registration fee: ATA24SPKNET
Hexoskin @ 2024 JP Morgan Conference
Hexoskin will be in San Francisco again this year during the 42nd Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.
We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
Hexoskin @ HITLAB Innovators Summit 2023
This November at the HITLAB Innovators Summit at Columbia University in NYC we officially launched our new Hexoskin OneView platform for clinical research! For a long time we knew there was a need for better software to support digital biomarker development and clinical research with medical wearables.
We understand the needs of research organizations and clinical sites when it comes to onboarding participants, monitoring compliance and data quality.
So we did something about it.
OneView is the best solution for doing clinical research with Hexoskin and Astroskin wearables. It allows you to:
- Manage cohorts and calendars
- Monitor data quality and compliance
- Use study templates, standardized questionnaires and data reports
- Easily clone studies to create new study arms
- Export all data to other systems like R and SAS for biostatistics
The platform also includes a mobile app for patient reported outcomes and participant tasks management.
On top of that, Hexoskin offers turnkey services for clinical trials: protocol planning and design, recruitment, study support, biostatistics and endpoints, etc.
OneView is already used today by a select group of research organizations and Pharma companies - who joined our beta program earlier this year - to run clinical trials with a decentralized or virtual component. Their feedback has been amazing and has helped us improve OneView to make it an essential research tool.
Please visit our website: hexoskin.com/oneview to learn more about digital tools for clinical research.
The recording from the event is available below:
